Vitamin D Analogues and Fracture Risk in Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Vitamin D receptor agonists (VDRAs) are commonly prescribed in chronic kidney disease (CKD). However, their protective effects on bone remain controversial. We performed a systematic review and meta‐analysis of randomized controlled trials (RCTs) to evaluate the effect of VDRAs on fracture risk and...

Descripción completa

Detalles Bibliográficos
Autores principales: Khelifi, Nada, Desbiens, Louis‐Charles, Sidibé, Aboubacar, Mac‐Way, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009117/
https://www.ncbi.nlm.nih.gov/pubmed/35434454
http://dx.doi.org/10.1002/jbm4.10611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009117/
https://www.ncbi.nlm.nih.gov/pubmed/35434454
http://dx.doi.org/10.1002/jbm4.10611

Ejemplares similares